| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $316.4M | +27.4% |
| R&D Expense | $83.9M | +28.8% |
| SG&A Expense | $91.4M | -4.6% |
| Operating Income | -$87.4M | +19.6% |
| Interest Expense | $20.7M | +3.2% |
| Pre-tax Income | -$101.0M | +50.6% |
| Income Tax | $321K | +106.9% |
| Net Income | -$101.3M | +49.3% |
| EPS (Basic) | -$0.51 | +80.7% |
| EPS (Diluted) | -$0.51 | +80.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $350.6M | -37.7% |
| Short-term Investments | $111.0M | — |
| Accounts Receivable | $39.7M | +28.1% |
| Current Assets | $1.81B | -2.7% |
| Total Assets | $2.21B | -2.4% |
| Current Liabilities | $1.39B | +4.4% |
| Long-term Debt | $83.7M | -34.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.7M | +58.2% |
| Investing Cash Flow | -$140.3M | -66.9% |
| Financing Cash Flow | -$1.7M | -100.1% |
| Total Liabilities |
| $1.55B |
| +0.7% |
| Stockholders' Equity | $657.4M | -9.1% |